Germline mutation rate predicts cancer mortality across 37 vertebrate species
- PMID: 39233763
- PMCID: PMC11372239
- DOI: 10.1093/emph/eoae016
Germline mutation rate predicts cancer mortality across 37 vertebrate species
Abstract
Background and objectives: Cancer develops across nearly every species. However, cancer occurs at unexpected and widely different rates throughout the animal kingdom. The reason for this variation in cancer susceptibility remains an area of intense investigation. Cancer evolves in part through the accumulation of mutations, and therefore, we hypothesized that germline mutation rates would be associated with cancer prevalence and mortality across species.
Methodology: We collected previously published data on germline mutation rate and cancer mortality data for 37 vertebrate species.
Results: Germline mutation rate was positively correlated with cancer mortality (P-value = 0.0008; R2 = 0.13). Controlling for species' average parental age, maximum longevity, adult body mass or domestication did not improve the model fit (the change (Δ) in Akaike Information Criterion (AIC) was less than 2). However, this model fit was better than a model controlling for species trophic level (ΔAIC > 2).
Conclusions and implications: The increased death rate from cancer in animals with increased germline mutation rates may suggest underlying hereditary cancer predisposition syndromes similar to those diagnosed in human patients. Species with higher germline mutation rates may benefit from close monitoring for tumors due to increased genetic risk for cancer development. Early diagnoses of cancer in these species may increase their chances of overall survival, especially for threatened and endangered species.
Keywords: animals; germ cell mutations; malignancy; tumor.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.
Conflict of interest statement
J.D.S. is a co-founder and shareholder employed by Peel Therapeutics, Inc., and L.M.A. is a shareholder and consultant to Peel Therapeutics, Inc.
Figures


Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
Cited by
-
The Elephant and the Spandrel.Evol Med Public Health. 2024 Aug 26;13(1):92-100. doi: 10.1093/emph/eoae019. eCollection 2025. Evol Med Public Health. 2024. PMID: 40276264 Free PMC article.
-
Cancer Prevalence across Vertebrates.Cancer Discov. 2025 Jan 13;15(1):227-244. doi: 10.1158/2159-8290.CD-24-0573. Cancer Discov. 2025. PMID: 39445720 Free PMC article.
-
The relationship between diet, plasma glucose, and cancer prevalence across vertebrates.Nat Commun. 2025 Mar 12;16(1):2271. doi: 10.1038/s41467-025-57344-1. Nat Commun. 2025. PMID: 40074744 Free PMC article.
References
-
- Zhu L, Beichman AC, Harris K.. Reproductive life history may modulate selection on the germline mutation rate. bioRxiv 2023:2023.12.06.570457.
-
- Lynch M, Ackerman MS, Gout J-F. et al. Genetic drift, selection and the evolution of the mutation rate. Nat Rev Genet 2016;17:704–14. - PubMed
-
- Zhang J, Pei R, Pang Z. et al. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat 2012;132:421–8. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources